Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYP2C19 genetic variants and platelet activity in patients undergoing coronary angioplasty
RBR-6n87rsCompleted
- Sponsor
- Faculdade de Medicina de Ribeirão Preto
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of clopidogrel in coronary arteriosclerosis, sponsored by Faculdade de Medicina de Ribeirão Preto. Primary endpoints: Genetic polymorphisms in CYP2C19, PON1, and ABCB1 and Platelet activity by light transmission aggregometry. Started Jan 2010; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on RBR-6n87rs.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6n87rs.